Cargando…
In Reply
This letter to the editor responds to remarks on a recently published article about dermatologic events associated with enfortumab vedotin and agrees that education on the prevention and management of such events should be a priority.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526498/ https://www.ncbi.nlm.nih.gov/pubmed/36036599 http://dx.doi.org/10.1093/oncolo/oyac171 |
| _version_ | 1784800888623202304 |
|---|---|
| author | Lacouture, Mario E Patel, Anisha B Rosenberg, Jonathan E O’Donnell, Peter H |
| author_facet | Lacouture, Mario E Patel, Anisha B Rosenberg, Jonathan E O’Donnell, Peter H |
| author_sort | Lacouture, Mario E |
| collection | PubMed |
| description | This letter to the editor responds to remarks on a recently published article about dermatologic events associated with enfortumab vedotin and agrees that education on the prevention and management of such events should be a priority. |
| format | Online Article Text |
| id | pubmed-9526498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95264982022-10-03 In Reply Lacouture, Mario E Patel, Anisha B Rosenberg, Jonathan E O’Donnell, Peter H Oncologist Letter to the Editor This letter to the editor responds to remarks on a recently published article about dermatologic events associated with enfortumab vedotin and agrees that education on the prevention and management of such events should be a priority. Oxford University Press 2022-08-29 /pmc/articles/PMC9526498/ /pubmed/36036599 http://dx.doi.org/10.1093/oncolo/oyac171 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Lacouture, Mario E Patel, Anisha B Rosenberg, Jonathan E O’Donnell, Peter H In Reply |
| title | In Reply |
| title_full | In Reply |
| title_fullStr | In Reply |
| title_full_unstemmed | In Reply |
| title_short | In Reply |
| title_sort | in reply |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526498/ https://www.ncbi.nlm.nih.gov/pubmed/36036599 http://dx.doi.org/10.1093/oncolo/oyac171 |
| work_keys_str_mv | AT lacouturemarioe inreply AT patelanishab inreply AT rosenbergjonathane inreply AT odonnellpeterh inreply |